Management of HIV Drug-Resistant Infections
Reference119 articles.
1. Sardana VV, Emini EA, Gotlib L,Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple non-nucleoside inhibitors. J Biol Chem 1992; 267; 17, 526–17, 530.
2. Erickson JW, Burt SK. Structural mechanisms of HIV drug resistance. Ann Rev Pharmacol Toxicol 1996; 36: 545–571.
3. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243: 1731–1734.
4. Kozal MJ, Shah N, Shen N,Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med 1996; 2: 753–758.
5. Descamps D, Collin G, Letourneur F,Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 1997; 71: 8893–8898.